Srdan Verstovsek, MD, PhD¹, Andrew Kuykendall, MD², Ronald Hoffman, MD³, Steffen Koschmieder⁴, Francesco Passamonti, MD^5*, Frank Valone, MD^6*, Nishit B. Modi, PhD^6*, Sarita Khanna, PhD^6*, Paula G. O'Connor, MD^6*, Suneel K. Gupta, PhD⁶ and Jean-Jacques Kiladjian, MD⁷

¹Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, University Hospital of Aachen, Aachen, Germany
⁵Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy
⁶Protagonist Therapeutics, Inc, Newark, CA
⁷Hôpital Saint-Louis; Université de Paris, INSERM, Paris, France Centre d’Investigations Cliniques, Université Paris, AP-HP, Hôpital Saint-Louis, Paris, France

Daniel J. DeAngelo, MD, PhD^1*, Deepti H. Radia, MRCPI, FRCPath^2*, Tracy I. George, MD³, William A. Robinson, MD, PhD^4*, Albert T. Quiery, MD^5,6, Mark W. Drummond, PhD, FRCPath^7*, Prithviraj Bose, MD⁸, Elizabeth O. Hexner, MD, MSTR⁹, Elliott Winton, MD¹⁰, Hans-Peter Horny, MD^11*, Meera Tugnait, PhD^12*, Hui-Min Lin, PhD^13*, Saša Dimitrijević, PhD^14*, Javier I. Munoz-Gonzalez, PhD^14*, Ilda Bidollari, MD, MBA^13*, Michael W. Deininger, MD, PhD¹⁵ and Jason Gotlib, MD, MS¹⁶

¹Dana-Farber Cancer Institute, Boston, MA
²Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom
³ARUP Laboratories, Salt Lake City, UT
⁴UC Denver, Aurora, CO
⁵University of Michigan, Ann Arbor, MI
⁶U of M Cancer Center, Ann Arbor, MI
⁷Beatson Cancer Centre, Glasgow, United Kingdom
⁸The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, Philadelphia, PA
¹⁰Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
¹¹Institute of Pathology, Ludwig-Maximilians University, Munich, Germany
¹²Cerevel Therapeutics, Cambridge, MA
¹³Blueprint Medicines Corporation, Cambridge, MA
¹⁴Blueprint Medicines (Switzerland) GmbH, Zug, Switzerland
¹⁵Versiti Blood Research Institute, Milwaukee, WI
¹⁶Department of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, San Carlos, CA

Vikas Gupta, MD, FRCP, FRCPath¹, Abdulraheem Yacoub, MD², Srdan Verstovsek, MD, PhD³, Ruben Mesa, MD, FACP⁴, Claire N. Harrison, DM⁵, Alessandro M. Vannucchi, MD^6*, Jean-Jacques Kiladjian^7*, H. Joachim Deeg, MD⁸, Salman Fazal, MD^9*, Lynda Foltz^10*, Ryan J. Mattison, MD¹¹, Carole B. Miller, MD^12*, Vinod Parameswaran, MD^13*, Patricia Martin-Regueira, MD^14*, Christopher Hernandez, MSc^14*, Jia Wang^14* and Moshe Talpaz, MD^15*

¹Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
²The University of Kansas Hospital, Kansas City, KS
³MD Anderson Cancer Center, Houston, TX
⁴Mays Cancer Center, San Antonio, TX
⁵Guy's Hospital, London, ENG, United Kingdom
⁶Università di Firenze, AOU Careggi, CRIMM, Florence, Italy
⁷Hopital Saint-Louis et Universite Paris, Paris, France
⁸Fred Hutchinson Cancer Research Center, Seattle, WA
⁹Allegheny Health Network, Pittsburgh, PA
¹⁰University of British Columbia, Vancouver, BC, Canada
¹¹University of Wisconsin Hospitals, Madison, WI
¹²Ascension Saint Agnes Cancer Institute, Baltimore, MD
¹³Avera Cancer Institute, Sioux Falls, SD
¹⁴Bristol Myers Squibb, Princeton, NJ
¹⁵University of Michigan, Ann Arbor, MI

Jeanne M. Palmer, MD¹, Aaron T. Gerds, MD, MS², Claire N. Harrison, DM^3,4, Jean-Jacques Kiladjian, MD⁵, Sarah Buckley, MD^6*, Karisse Roman-Torres^6*, John Mascarenhas, MD⁷ and Ruben Mesa, MD, FACP⁸

¹Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ
²Taussig Cancer Institute, Department of Hematology & Medical Oncology, Cleveland Clinic, Cleveland, OH
³Guys and St Thomas NHS Trust, London, United Kingdom
⁴Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
⁵Hopital Saint-Louis, Paris, France
⁶CTI BioPharma, Seattle, WA
⁷Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Mays Cancer Center at UT Health San Antonio, San Antonio, TX

Terrence Bradley, MD¹, Andrew Kuykendall, MD², Rami S. Komrokji³, Tymara Berry, MD^4*, Souria Dougherty, BS, MBA^4*, Laurie Sherman, BSN⁴, Lixian Peng, PhD^4*, Fei Huang, PhD⁴, Ying Wan, PhD^4*, Faye Feller, MD⁴ and John Mascarenhas, MD⁵

¹University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
⁴Geron Corporation, Parsippany, NJ
⁵Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Sanjay R Mohan, MD, MSCI¹, Stephen T Oh, MD, PhD², Haris Ali, MD³, Anthony M. Hunter, MD^4*, Francesca Palandri, PhD, MD^5*, Betty Lamothe, PhD⁶, Yi Cui, PhD^6*, Francis Seguy, MSc^7*, Amanda McBride, MD, PhD⁶, Michael Robert Savona^8*, Jean-Jacques Kiladjian, MD⁹ and Srdan Verstovsek, MD, PhD¹⁰

¹Vanderbilt University School of Medicine, Vanderbilt Ingram Cancer Center, Nashville, TN
²Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
³City of Hope Medical Center, Duarte, CA
⁴Emory University School of Medicine, Atlanta, GA
⁵IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy
⁶Incyte Corporation, Wilmington, DE
⁷Incyte Biosciences International Sàrl, Morges, Switzerland
⁸Vanderbilt University Medical Center, Nashville, TN
⁹Hopital Saint-Louis, Paris, France
¹⁰Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX

Naseema Gangat, MBBS¹, Kebede H. Begna, MD², Aref Al-Kali, MD¹, William J. Hogan, MB, BCh¹, Mark R. Litzow, MD¹, Animesh Pardanani, MBBS, PhD ¹ and Ayalew Tefferi, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Divison of Hematology, Mayo Clinic, Rochester, MN

Ross Baker, MBBS, BMedSc^1*, Jana Baskar, MBBS, MMedSc^2*, Brett Charlton, MD, PhD^2*, Gabriela S. Hobbs, MD³, Wolfgang Jarolimek, PhD^2*, Sung-Eun Lee, MD^4*, Lucia Masarova, MD⁵ and Anne-Marie Watson, MBBS, FRACP, FRCPA⁶

¹Perth Blood Institute, Murdoch University, Perth, Australia
²Pharmaxis Ltd, Frenchs Forest, NSW, Australia
³Cancer Center, Massachusetts General Hospital, Boston, MA
⁴Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Liverpool Hospital, Sydney, NSW, Australia

Marie H. Kristiansen, MD^1,2*, Vibe Skov, PhD^3*, Lasse Kjær, PhD^3*, Morten Kranker Kranker Larsen, MSc^1,3*, Christina Ellervik, PhD^1,4,5*, Hans Carl Hasselbalch, MD^1,3 and Troels Wienecke, PhD^1,2*

¹Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
²Department of Neurology, Zealand University Hospital, Roskilde, Denmark
³Department of Hematology, Zealand University Hospital, Roskilde, Denmark
⁴Department of Data and Data Support, Region Zealand, Sorø, Denmark
⁵Department of Pathology, Harvard Medical School, Boston, MA

Tim Kong, MS¹, LaYow Yu^2*, Angelo BA Laranjeira, PhD^2*, Fan He, PhD², Maggie J. Allen, BS^2* and Stephen T Oh, MD, PhD¹

¹Division of Hematology, Washington University School of Medicine, St. Louis, MO
²Division of Hematology, Washington University School of Medicine in St. Louis, Saint Louis, MO

Erin Peckham-Gregory, PhD, MPH¹, Priya B Shetty, PhD^2*, Howard Lin, BS^3*, Brooks Scull, MS^3*, Erik Ehli, PhD^4*, Kenneth L. McClain, MD, PhD⁵, Philip J. Lupo, Ph.D., M.P.H.^6*, Carl E. Allen, MD, PhD⁷ and Michael E. Scheurer, PhD, MPH^8*

¹Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
²Baylor College of Medicine, Houston
³Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX
⁴Avera Institute for Human Genetics, Sioux Falls
⁵Texas Childrens Cancer and Hematology Centers, Houston, TX
⁶Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, TX
⁷Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX
⁸Texas Children's Hematology Center, Baylor College of Medicine, Department of Pediatrics, Section of Hematology/Oncology, Houston, TX

Chiara Maccari^1*, Benedetta Sordi, MD.^1*, Paola Guglielmelli, MD, PhD², Manjola Balliu, PhD^1*, Alessandro Atanasio, MD^1*, Carmela Mannarelli, PhD^1*, Giulio Capecchi, MD^1*, Ilaria Sestini, LabTech^3*, Giacomo Coltro, MD^1*, Giada Rotunno, PhD^1*, Eva Angori, BiSc Stud^4*, Filippo C. Borri, MedStud^4*, Natasha Szuber, MD, MSc⁵ and Alessandro Vannucchi, MD¹

¹CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
²CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy
³CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Florence, Italy
⁴University of Florence, Florence, Italy
⁵Maisonneuve-Rosemont Hospital, Department of Hematology, Montreal, QC, Canada

Shiwei Hu^1,2,3*, Danhong Xiang^1,2,3*, Min Yang, M.D.^1* and Jian Huang, MD, PhD^1,2,3

¹Department of Hematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
²Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, China
³Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China

Guangshuai Teng^1*, Yuhui Zhang^1*, Chenxiao Du^1*, Yan Wang^2*, Naibo Hu^1*, Yingdi Han^1*, Jinyu Ma^2*, Shan Gao^2*, Guangpeng Xiang^2*, Zonghong Shao¹ and Jie Bai, MD¹

¹Department of Hematology, The Second Hospital of Tianjin Medical University, Tianjin, China
²Second Hospital of Tianjin Medical University, tianjin, China

Ghaith Abu-Zeinah, MD¹, Spencer Krichevsky, MS^2,3*, Katie Erdos^2*, Richard T. Silver, MD² and Joseph Scandura, MD, PhD²

¹Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Cornell, New York, NY
²Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY
³Department of Biomedical Informatics, State University of New York at Stony Brook, Stony Brook, NY

Abdulrahman F Al-Mashdali, MD^1*, Alaa Rahhal^2*, Mahmood B Aldapt, MBBS³, Elrazi Awadelkarim Ali^1*, Yousef Mohammed Hailan, MBBS^4*, Waail Rozi Kashgary^1* and Mohamed A Yassin, MBBS, MSC, CABM, MSC, FACP⁵

¹Internal Medicine, Hamad Medical Corporation, Doha, Qatar
²Pharmacy Department, Hamad Medical corporation, Doha, Qatar
³National Center for Cancer Care and Research HMC, Doha, Qatar
⁴Department of Medicine, Hamad Medical Corporation, Doha, Qatar
⁵Department of Medical Oncology/ Hematology Section, National Centre For Cancer Care & Research, Doha, Qatar

Xin Yan, MD^1*, Zefeng Xu^1*, Shiqiang Qu^1*, Tiejun Qin^1*, Gang Huang, PhD², Zhijian Xiao, MD&PhD^3* and Bing Li, MD^1*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Jean-Jacques Kiladjian, MD¹, Françoise Boyer perrard^2*, Kamel Laribi, MD^3*, Jean-Christophe Ianotto, MD, PhD^4*, Dana Ranta, MD^5*, Omar Benbrahim, MD^6*, Serge Bologna, MD^7*, Pascale Cony-Makhoul, MD^8*, Alberto Santagostino^9*, Hacene Zerazhi^10*, Abla Slimani^11*, Olivier Fitoussi, MD^12* and Gabriel Etienne, MD, PhD^13*

¹Centre d’Investigations Cliniques, Hôpital Saint-Louis, Paris, France
²Service des maladies du sang, Centre Hospitalier Universitaire d’Angers, Angers, France
³Hématologie clinique, CH Le Mans, Le Mans, France
⁴Clinical Hematology, Institut de Cancéro-Hématologie, Brest University Hospital, Brest, France
⁵Centre Hospitalier Universitaire, Nancy, France
⁶Hematology Department, CHR Orléans, Orleans, France
⁷Clinique Louis Pasteur, Essey-lès-Nancy, France
⁸Service d'Hématologie, Centre Hospitalier Annecy-Genevois, Pringy, France
⁹Hematology, CH de Troyes, Troyes, France
¹⁰Hématologie, CH Avignon, Avignon, France
¹¹Novartis, Rueil Malmaison, WY, France
¹²Service d’oncologie-hématologie-radiothérapie, Polyclinique Bordeaux-Nord, Bordeaux, France
¹³Hematology Department, Institut Bergonié, Bordeaux, France

Johannes Lübke, MD^1*, Nicole Naumann, PhD^1*, Sebastian Kreil, MD, PhD^1*, Georgia Metzgeroth, MD^1*, Hans-Peter Horny, MD^2*, Karl Sotlar, MD^3*, Nicholas C.P. Cross, PhD⁴, Alice Fabarius, PhD^1*, Peter Valent, MD^5,6, Wolf-Karsten Hofmann, MD¹, Juliana Schwaab, MD^1* and Andreas Reiter, MD⁷

¹Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
²Institute of Pathology, Ludwig-Maximilians-University, Munich, Munich, Germany
³Institute of Pathology, Medical University of Salzburg, Salzburg, Austria
⁴Faculty of Medicine, University of Southampton, Southampton, United Kingdom
⁵Ludwig Boltzmann Institute for Hematology and Oncology, Vienna, Austria
⁶Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
⁷Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany

Laura F. Mendez, MD, PhD¹, Jiarui Li, RD^2*, Julio Avelar-Barragan^3*, Jenny Nguyen^4*, Hellen Nguyen^4*, Heidi E. Kosiorek, MS^5*, Ruben Mesa, MD, FACP⁶, Robyn Marie Scherber, MD, MPH^7*, Katrine Whiteson, PhD^8*, Andrew Odegaard, PhD, MPH^9* and Angela G Fleischman, MD, PhD³

¹University of California Irvine, Irvine, CA
²Department of Epidemiology, University of California, Irvine, Irvine, CA
³University of California, Irvine, Irvine, CA
⁴Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, CA
⁵Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
⁶Mays Cancer Institute, UT Health San Antonio MD Anderson, San Antonio, TX
⁷Mays Cancer Center at UT Health San Antonio and MD Anderson Cancer Center, San Antonio, TX
⁸UNIVERSITY OF CALIFORNIA, IRVINE, IRVINE, CA
⁹Department of Epidemiology, University of California Irvine, Irvine, CA

Aaron T. Gerds, MD, MS¹, Claire N. Harrison, DM², Stephen Thompson^3*, Frank Snopek, PharmD^3* and Naveen Pemmaraju, MD⁴

¹Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom
³Sierra Oncology, Inc., San Mateo, CA
⁴MD Anderson Cancer Center, Houston, TX

Christopher J. Saunders, MD^1*, Chandan Saha^1*, Priya Sriskandarajah^1*, Helen Cashman^2*, Andrew J Wilson^2*, Jonathan Lambert^2*, Matthew Lawes^3*, David Tucker, MD^4*, Simone Green^5*, Manish Jain^6*, Victoria Stables^7*, Juanah Addada^8*, Theingi Yin^9*, Huw Roddie^10*, Bethan Psaila, MD, PhD¹¹ and Deepti H. Radia, MRCPI, FRCPath^12*

¹Guy's and St. Thomas' Hospital NHS Foundation Trust, London, United Kingdom
²University College London Hospitals NHS Foundation Trust, London, United Kingdom
³Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, United Kingdom
⁴Royal Cornwall Hospital, Cornwall, United Kingdom
⁵Hull University Teaching Hospitals NHS Foundation Trust, Hull, United Kingdom
⁶St James University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
⁷Maidstone and Turnbridge Wells NHS Trust, Turnbridge Wells, United Kingdom
⁸Royal Derby Hospital, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom
⁹University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, United Kingdom
¹⁰Edinburgh Cancer Center, Western General Hospital, Edinburgh, United Kingdom
¹¹MRC Weatherall Institute of Molecular Medicine, University of Oxford; Oxford University Hospitals NHS Trust, Oxford, United Kingdom
¹²Guy's and St. Thomas' Hospital, London, United Kingdom

Peter Loffelhardt, DO^1*, Ryan Eckert, MS^2*, Judit Diaz Campos^1*, Ruben Mesa, MD, FACP² and Carles Besses Raebel, MD, PhD³

¹Asociación de Afectados por Neoplasias Mieloproliferativas, Barcelona, Spain
²Mays Cancer Center at UT Health San Antonio, San Antonio, TX
³Cancer Research Program-IMIM, Group of Applied Clinical Research in Hematology, Barcelona, Spain

Srdan Verstovsek, MD, PhD¹, Jason Gotlib, MD, MS², Alessandro M. Vannucchi, MD^3*, Alessandro Rambaldi, MD⁴, Andreas Reiter, MD⁵, William Shomali, MD², Tracy I. George, MD⁶, Jay L. Patel, MD^7*, Philomena Colucci, DO, MS^8*, Huiling Zhen, PhD^8*, Natalia Oliveira, MBA, BS^8* and Jean-Jacques Kiladjian, MD⁹

¹University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Hematology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
³University of Florence, CRIMM, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
⁴Department of Oncology and Hematology, University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁵University Hospital Mannheim, Heidelberg University, Mannheim, Germany
⁶Department of Pathology, ARUP Laboratories, University of Utah School of Medicine, Salt Lake City, UT
⁷ARUP Laboratories and University of Utah School of Medicine, Salt Lake City, UT
⁸Incyte Corporation, Wilmington, DE
⁹Hôpital Saint-Louis, Paris, France

Ruben Mesa, MD, FACP¹, Srdan Verstovsek, MD, PhD², Uwe Platzbecker, MD^3*, Vikas Gupta, MD, FRCP, FRCPath⁴, David Lavie, MD^5*, Pilar Giraldo, PhD⁶, Jean-Jacques Kiladjian, MD⁷, Stephen T Oh, MD, PhD⁸, Timothy Devos, MD, PhD⁹, Francesco Passamonti, MD^10*, Miklos Egyed, MD, PhD^11*, Alessandro Vannucchi, MD¹², Andrzej Pluta, MD^13*, Donal P McLornan, MD, MRCP, PhD, FRCPath^14*, Jun Kawashima, MD^15*, Mei Huang, MS^15*, Bryan Strouse, MSc^15* and Claire N. Harrison, DM¹⁶

¹Mays Cancer Center at UT Health San Antonio, San Antonio, TX
²MD Anderson Cancer Center, University of Texas, Houston, TX
³Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
⁴Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
⁵Hadassah-Hebrew University Medical Centre, Jerusalem, Israel
⁶Miguel Servet University Hospital and Centro de Investigacion Biomedica en Red de Enfermadades Raras (CIBERER), Zaragoza, Spain
⁷Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d’Investigations Cliniques, Paris, France
⁸Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
⁹Department of Hematology and Department of Microbiology and Immunology, University Hospitals Leuven and Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium
¹⁰University of Insubria, Varese, Italy
¹¹Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary
¹²University of Florence, Azienda Ospedaliero Universitaria Careggi, CRIMM, Florence, Italy
¹³Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. Ks. B. Markiewicza, Brzozów, Poland
¹⁴Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
¹⁵Sierra Oncology Inc., San Mateo, CA
¹⁶Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom

Haris Ali, MD¹, Ashwin Kishtagari, MBBS², Keri Maher, DO³, Sanjay R Mohan, MD, MSCI⁴, Karen Ansaldo^5*, Xulong Wang^5*, Kamal Chamoun, MD^5*, Josef T. Prchal, MD⁶ and Srinivas K. Tantravahi, MBBS⁷

¹City of Hope Medical Center, Duarte, CA
²Division of Hematology & Oncology, Vanderbilt Ingram Cancer Center, Franklin, TN
³Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ
⁴Vanderbilt University School of Medicine, Vanderbilt Ingram Cancer Center, Nashville, TN
⁵Karyopharm Therapeutics, Newton, MA
⁶Division of Hematology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁷Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Michal Bar-Natan, MD¹, John Mascarenhas, MD², Aaron T. Gerds, MD, MS³, Ruben Mesa, MD, FACP⁴, Vikas Gupta, MD, FRCP, FRCPath⁵, Marina Kremyanskaya, MD, PhD⁶, Mikaela Dougherty^1*, Frank Fabris^1*, Kathryn Johnson^7*, Ashley Yu, MBA, BS^8*, Heidi E. Kosiorek, MS^9*, Carolyn Mead-Harvey, MS^10*, Amylou C. Dueck, PhD⁹, Ronald Hoffman, MD⁶ and Raajit K Rampal, MD, PhD¹¹

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
³Department of Hematology and Medical Oncology,, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁴Mays Cancer Center at UT Health San Antonio, San Antonio, TX
⁵Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
⁶Tisch Cancer Institute, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁷Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
⁸Tisch Cancer Institute, Icahn School oh Medicine at Mount Sinai, New York, NY
⁹Department of Health Sciences Research, Mayo Clinic, Scottsdale, AZ
¹⁰Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ
¹¹Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY

Kayleigh Rutherford, MS^1*, Noushin Farnoud, PhD^1*, Aishwarya Krishnan, MS^2*, Raajit K Rampal, MD, PhD³, Ross L. Levine, MD^1,3,4 and Nicole Kucine, MD, MS⁵

¹Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
²Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO
³Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Pediatrics, Weill Cornell Medicine, New York, NY

Franco Castillo Tokumori, MD¹, Joseph Scandura, MD, PhD² and Ghaith Abu-Zeinah, MD²

¹NewYork Presbyterian Hospital/ Weill Cornell, New York, NY
²Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY

Gordon Ruan, MD¹, Jithma P. Abeykoon, MD¹, Aldo A. Acosta Medina, MD², Saurabh Zanwar, MBBS^1*, Aishwarya Ravindran, MBBS³, Karen Rech, MD^4*, Jason R. Young, MD^5*, Jay Ryu, MD^6*, Matthew Koster, MD^7*, W. Oliver Tobin, MB BCh^8*, Mithun V. Shah, MD, PhD¹, N. Nora Nora Bennani, MD¹, Robert Vassallo, MD^6*, Baylie Brooks^9*, Ginny-Tyler Meadows^9*, Abby McCrory, MSN^9*, Diana Morlote, MD^10*, Gaurav Goyal, MD⁹ and Ronald Go, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Internal Medicine, Mayo Clinic, Rochester, MN
³Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL
⁴Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁵Department of Radiology, Mayo Clinic, Jacksonville, FL
⁶Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN
⁷Division of Rheumatology, Mayo Clinic, Rochester, MN
⁸Department of Neurology, Mayo Clinic, Rochester, MN
⁹Hematology/Oncology, University of Alabama At Birmingham, Birmingham, AL
¹⁰University of Alabama At Birmingham, Birmingham, AL

Levi-Dan Azoulay^1*, Chezi Ganzel, MD^2*, Marine Bravetti, MD^3*, Zahir Amoura, MD, MSc^4*, Jean Donadieu⁵, Philippe Cluzel, MD, PhD^3*, Fleur Cohen-Aubart, MD, PhD^1* and Julien Haroche, MD, PhD^1*

¹Department of Internal Medicine 2, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
²Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
³Department of Interventional and Cardiovascular Radiology, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France
⁴Department of Internal Medicine 2, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, FRA
⁵Department of Pediatric Hematology-Oncology, Reference Center for Chronic Neutropenia, National Registry of Congenital Neutropenia, Hopital Trousseau, Paris, France

Reem S. Chamseddine, BSc^1*, Shehroz Rana^1*, Mohammed Khalid^1*, Nicole Kucine, MD, MS², Richard T. Silver, MD³, Joseph Scandura, MD, PhD³ and Ghaith Abu-Zeinah, MD³

¹Weill Cornell Medicine-Qatar, Doha, Qatar
²Department of Pediatrics, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY
³Richard T. Silver, M.D. Myeloproliferative Neoplasms (MPN) Center, Weill Cornell Medicine, New York, NY